National Institute on Alcohol Abuse and Alcoholism (NIAAA)s

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

28 Protocols (15 Active Accrual of new subjects, 13 Follow-up of previously enrolled subjects)

 002228-AA:

Role of Metal Ion Transporter ZIP8 in Alcohol Related Behaviors

 001644-AA:

Temporally-Resolved Electrophysiology of Acamprosate Treatment of Alcohol Use Disorder

 001561-AA:

Suvorexant for Alcohol Use Disorder (AUD): Neural Mechanisms

 000421-AA:

Individual Variations of Taste and Smell Perception in Alcohol Use Disorder (AUD)

 000406-AA:

Addictions Neuroclinical Assessment

 000261-AA:

Mechanisms Underlying Individual Variations of Taste and Smell in Obesity

 000071-AA:

Repository of Research Data and Samples, National Institute on Alcohol Abuse and Alcoholism

 000036-AA:

A Phase I, Randomized, Double-Blind, Placebo-Controlled, Study of Safety, Tolerability, and Bioeffects of Alirocumab in Non-treatment Seeking Heavy Drinkers

 20-AA-0115:

COVID-19 Pandemic Impact on Alcohol (PIA) - A Natural History Study

 18-AA-0047:

Effects of Sucralose on Drug Absorption and Metabolism (The SweetMeds Study)

 17-AA-0171:

Nicotinic Receptor Genetic Variation and Alcohol Reward

 15-AA-0186:

Development of Neuroimaging Methods to Assess the Neurobiology of Addiction

 14-AA-0181:

NIAAA Natural History Protocol

 14-AA-0080:

Characterization Imaging Instruments for Addiction Neuroimaging Assessments

 14-AA-0066:

Behavioral and Functional Task Development, Implementation, and Testing

 002246-AA:

A Randomized, Double-Blind, Placebo-Controlled, Flexible Dose Phase 2 Study of Efficacy and Safety of Tirzepatide in Individuals with Alcohol Use Disorder and Metabolic Alcohol-associated Liver Disease

 20-AA-0057:

The Effect of Acute Alcohol Intoxication on Neural Processes During Decisions to Engage in HIV Risk Behaviors

 19-AA-0075:

Manipulating Ghrelin Signaling via GOAT Inhibition in Alcohol Use Disorder

 18-AA-0098:

Investigating a Response Modulation Hypothesis of Socioemotional Processing associated with Alcohol Use Disorder

 17-AA-0178:

Dopaminergic Modulation of Brain Activation Using Simultaneous PET/Pharmacological MRI

 17-AA-0152:

Ketogenic Diet (KD) in Alcoholism

 17-AA-0114:

Brain Dopaminergic Signaling in Opioid use Disorders (OUD)

 16-AA-0059:

Characterization of Brain Amyloid-beta (A-beta) Retention During Wakefulness And Following Emergence From Sleep In Healthy Subjects

 16-AA-0037:

Effect of Opioid Receptor Modulation on Alcohol Self-Administration and Neural Response to Alcohol Cues in Heavy Drinkers: Role of OPRM1 Gene Variation

 15-AA-0127:

(Epi)genetic Modulators of Fear Extinction in Alcohol Dependence

 15-AA-0031:

Human Brain Mapping of the Apparent Diffusion Coefficient (ADC) during Sleep and Wakefulness

 14-AA-0192:

Brain Inflammation and Function in Alcoholism

 14-AA-0144:

Reliability Of The Human Brain Connectome

 08-AA-0178:

Computer-Assisted Self-Administration of Ethanol (CASE) in Humans